U.S. equities were mixed at midday, dropping from their morning highs after a federal trade court blocked some of President Donald Trump's tariffs. The S&P 500 and Nasdaq were up, the Dow Jones Industrial Average fell.

The government scraps funding deal for MRNA's bird flu shot, despite encouraging safety and efficacy data from early clinical studies on the vaccine.

UDR benefits from strong demand, favorable demographics and tech-driven efficiency, but high debt and new supply pressure are concerns.

Royal Bank of Canada (NYSE:RY ) Q2 2025 Earnings Conference Call May 29, 2025 8:30 AM ET Company Participants Asim Imran - Senior Vice President, Investor Relations Dave McKay - President & Chief Executive Officer Katherine Gibson - Chief Financial Officer Graeme Hepworth - Chief Risk Officer Derek Neldner - Group Head, Capital Markets Sean Amato-Gauci - Group Head, Commercial Banking Erica Nielsen - Group Head, Personal Banking Conference Call Participants Gabriel Dechaine - National Bank Financial Ebrahim Poonawala - Bank of America Mario Mendonca - TD Securities Paul Holden - CIBC Sohrab Movahedi - BMO Capital Markets Mike Rizvanovic …

In 2020, the tech giant set itself a target of drastically cutting its emissions by the end of the decade. With five years to go, the pressure is mounting.

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Rocket Companies, Inc. (NYSE: RKT).

The U.S. Federal Aviation Administration on Thursday said it would extend by three years a program that allows Boeing to perform some tasks on the agency's behalf.

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, alerts investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. …

E.l.f. Beauty announcing it will buy Hailey Bieber's brand, Rhode for $1 billion dollars. The move gives the cosmetics retailer access to a product line that has become hugely popular among Gen Z and millennials.

Tesla is a business built, in part, on government regulations and incentives, from a Department of Energy loan guarantee in 2009 to the regulatory credits it sells to other automakers, which have driven a third of its $32 billion in profits since 2012.

Despite commodity cost pressures and competition, Tootsie Roll's niche brand loyalty and sustainable payouts position it as a defensive dividend growth stock.

Foot Locker Q1 revenues decline as comparable sales fall Y/Y. Global traffic softness and store closures weigh on performance.

Discover why Zacks rates Medalist Diversified REIT as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore MDRR's promising growth prospects and financial health amid market challenges.

Jobless Claims Come in Higher.

The surge in operating expenses does not bode well for ZTO. A weak liquidity position also hurts the company's prospects.

The Facebook and Instagram parent is partnering with Luckey's Anduril Industries to develop combat VR headsets for the Army.

Dan Deming turns to a Big 3 that he expects to outperform in the coming weeks and months. He sees Oracle (ORCL) as a rising A.I.

LOS ANGELES , May 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). IF YOU SUFFERED A LOSS ON YOUR ELEVANCE INVESTMENTS, CLICK HERE BEFORE JULY 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES , May 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Digimarc Corporation ("Digimarc" or the "Company") (NASDAQ: DMRC). IF YOU SUFFERED A LOSS ON YOUR DIGIMARC INVESTMENTS, CLICK HERE BEFORE JULY 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES , May 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA). IF YOU SUFFERED A LOSS ON YOUR IOVANCE INVESTMENTS, CLICK HERE BEFORE JULY 14, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?